Press/Media
- 1 - 25 out of 32 results
Search results
-
Cells for Cells prepares to start commercial operations in Colombia in 2024 and advances plans in the U.S.
22/09/23
1 item of Media coverage
Press/Media
-
Findings from University of los Andes Advance Knowledge in Acute Respiratory Distress Syndrome (Safety and efficacy of clinical-grade, cryopreserved menstrual blood mesenchymal stromal cells in experimental acute respiratory distress syndrome)
Francisca Alcayaga-Miranda, Maroun Khoury & Francisco Espinoza
10/02/23
1 item of Media coverage
Press/Media
-
US Patent Issued to UNIVERSIDAD DE LOS ANDES, CELLS FOR CELLS on Jan. 31 for "Gelatin polymer derived from natural sources of cold-adapted marine species and uses thereof" (Chilean Inventors)
Juan Pablo Acevedo, Paulo César Díaz Calderón & Javier Ignacio Enrione
1/02/23
1 item of Media coverage
Press/Media
-
Patient Dosed With Mesenchymal Stem Cell-Derived Therapy for Osteoarthritis
25/07/22
1 item of Media coverage
Press/Media
-
CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis
18/07/22 → 19/07/22
19 items of Media coverage
Press/Media
-
CELLS for CELLS Treats the First-Ever Patient with an Exosome-Produced Therapy for Osteoarthritis
19/07/22
1 item of Media coverage
Press/Media
-
Cells for Cells treats first patient with exosome-produced therapy for osteoarthritis
19/07/22
1 item of Media coverage
Press/Media
-
CELLS For CELLS Treats The First-Ever Patient With An Exosome-Produced Therapy For Osteoarthritis
18/07/22
1 item of Media coverage
Press/Media
-
Cell for Cells starts cell therapy operations in the U.S. and closes agreement with the University of Miami
18/02/22
1 item of Media coverage
Press/Media
-
Revolutionary Chilean center will research the generation of new tissues and the use of cells to treat patients
2/01/22
1 item of Media coverage
Press/Media
-
US Patent Issued to Cells for Cells on June 22 for "Anti-angiogenic therapy based on exosomes derived from menstrual stem cells" (Chilean Inventors)
23/06/21
1 item of Media coverage
Press/Media
-
VEINTIS™ the tissue-engineered vascular graft developed by Cells for Cells, wins the 2020 National Innovation Prize
13/11/20
1 item of Media coverage
Press/Media
-
Australia Patent: Application for 'Anti-angiogenic therapy based on exosomes derived from menstrual stem cells' Lapses
16/10/20
1 item of Media coverage
Press/Media
-
Australia Patent: Application for 'Treatment for infection composed of menstrual stem cells' Lapses
15/10/20
1 item of Media coverage
Press/Media
-
Cells for Cells Applies for Patent on Method for Obtaining a Composition Containing a Specific Population of Umbilical Cord Mesenchymal Cells and Uses Thereof
26/09/20
1 item of Media coverage
Press/Media
-
Head Line: CELLS FOR CELLS S.A granted US Patent for "Device, platform, and assay for assessing cells"
10/09/20
1 item of Media coverage
Press/Media
-
US Patent Issued to CELLS FOR CELLS on Sept. 8 for "Device, platform, and assay for assessing cells" (Chilean Inventor)
9/09/20
1 item of Media coverage
Press/Media
-
Cells for Cells Obtains Patent for Device, Platform and Assay for Assessing Cells
9/09/20
1 item of Media coverage
Press/Media
-
Back from the dead? Advanced regenerative procedures revitalize dental pulp.
Maroun Khoury & Doctor Brizuela Cordero
27/08/20
1 item of Media coverage
Press/Media